Lovastatin
Product Images NDC 50090-0757

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 50090-0757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500900757)

Label Image (Lbl500900757)
Lovastatin 10 mg tablet bottle label from A-S Medication Solutions. The label includes the NDC 50090-0757-0, lot number, storage instructions to keep between 68 and 77 degrees Fahrenheit and protect from light. The package contains 30 tablets. Manufacturer information is partially visible with licensing details for Cardinals, Inc.*
FDA Label Image

Structural Formula (Lov00 0004 01)

Structural Formula (Lov00 0004 01)
Chemical structure of Lovastatin, showing its complex molecular arrangement including multiple rings and functional groups.*
FDA Label Image

Table I (Lov00 0004 02)

Table I (Lov00 0004 02)
A data table showing the effect of various coadministered drugs or grapefruit juice on lovastatin exposure. It includes number of subjects, dosing information for the coadministered agents and lovastatin, and the area under the curve (AUC) ratios comparing lovastatin exposure with and without coadministration.*
FDA Label Image

Figure 1 (Lov00 0004 03)

Figure 1 (Lov00 0004 03)
A line graph titled "Acute Major Coronary Events (Primary Endpoint)" comparing the proportion of participants without event over 6 years of follow-up between Lovastatin and placebo groups. The graph shows a 37% risk reduction with Lovastatin (p < 0.001) compared to placebo.*
FDA Label Image

Table Vii (Lov00 0005 04)

Table Vii (Lov00 0005 04)
Table listing drug interactions with lovastatin that increase risk of myopathy or rhabdomyolysis. It includes strong CYP3A4 inhibitors, HIV protease inhibitors, and other agents, with prescribing recommendations such as contraindication or dose limits for lovastatin and avoiding grapefruit juice.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.